GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » GlycoNex Inc (ROCO:4168) » Definitions » Other Current Payables

GlycoNex (ROCO:4168) Other Current Payables : NT$54.13 Mil (As of Mar. 2025)


View and export this data going back to 2012. Start your Free Trial

What is GlycoNex Other Current Payables?

GlycoNex's Other Current Payables for the quarter that ended in Mar. 2025 was NT$54.13 Mil.

GlycoNex's quarterly Other Current Payables increased from Sep. 2024 (NT$30.07 Mil) to Dec. 2024 (NT$32.36 Mil) and increased from Dec. 2024 (NT$32.36 Mil) to Mar. 2025 (NT$54.13 Mil).

GlycoNex's annual Other Current Payables increased from Dec. 2022 (NT$37.00 Mil) to Dec. 2023 (NT$40.44 Mil) but then declined from Dec. 2023 (NT$40.44 Mil) to Dec. 2024 (NT$32.36 Mil).


GlycoNex Other Current Payables Historical Data

The historical data trend for GlycoNex's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GlycoNex Other Current Payables Chart

GlycoNex Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Current Payables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 22.82 24.71 37.00 40.44 32.36

GlycoNex Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 86.16 35.79 30.07 32.36 54.13

GlycoNex Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.


GlycoNex Other Current Payables Related Terms

Thank you for viewing the detailed overview of GlycoNex's Other Current Payables provided by GuruFocus.com. Please click on the following links to see related term pages.


GlycoNex Business Description

Traded in Other Exchanges
N/A
Address
Section 1, Xintai 5th Road, 8th Floor, No. 97, Xizhi District, New Taipei City, TWN, 221
GlycoNex Inc is a Taiwan based company engaged in the development of cancer drugs from the combination of glycosphingolipid antigen and human monoclonal antibody technologies. It has a panel of antibodies that targets various carbohydrate antigens. The antibodies are cloned from hybridoma, engineered to improve stability, and can serve as reagents with applications that include ELISA, Western blot, flow cytometry, and TLC immunostaining. The Company also provides antibody research services to its academic and industrial clients. The other services provided by the firm include functional evaluation and antibody engineering. The company has two segments which are antibody new drugs and exclusive investment. It earns the majority of its revenue from the antibody new drugs segment.

GlycoNex Headlines

No Headlines